Journal
JOURNAL OF BIOLOGICAL CHEMISTRY
Volume 288, Issue 43, Pages 30892-30903Publisher
AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC
DOI: 10.1074/jbc.M113.477158
Keywords
-
Categories
Funding
- NCI of the National Institutes of Health [CA97098, CA166480]
Ask authors/readers for more resources
Aldehyde dehydrogenase 1A1 (ALDH1A1) activity is used as a marker of breast cancer stem cells; however, little is known about the regulation of ALDH1A1 expression. Mucin 1 (MUC1) is a heterodimeric protein that is aberrantly overexpressed in most human breast cancers. In studies of breast cancer cells stably silenced for MUC1 or overexpressing the oncogenic MUC1-Csubunit, we demonstrate that MUC1-Cis sufficient for induction of MEK -> ERK signaling and that treatment with a MUC1-Cinhibitor suppresses ERK activation. In turn, MUC1-C induces ERK-mediated phosphorylation and activation of the CCAAT/enhancer-binding protein beta (C/EBP beta) transcription factor. The results further show that MUC1-C and C/EBP beta form a complex on the ALDH1A1 gene promoter and activate ALDH1A1 gene transcription. MUC1-C-induced up-regulation of ALDH1A1 expression is associated with increases in ALDH activity and is detectable in stem-like cells when expanded as mammospheres. These findings demonstrate that MUC1-C (i) activates a previously unrecognized ERK -> C/EBP beta -> ALDH1A1 pathway, and (ii) promotes the induction of ALDH activity in breast cancer cells.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available